BRCA2 and ovarian carcinoma: Common genetic variation (represented by single nucleotide polymorphisms (SNPs)) at loci encoding for functional interactors of BRCA1 and/or BRCA2 modify breast and/or ovarian cancer risk in carriers of germline BRCA1 and/or BRCA2 mutations [37,38].